Clinical Trial Update: Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia [NA]

View source ↗

Summary

A clinical trial update evaluating adjunctive aripiprazole for risperidone-induced hyperprolactinemia in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)
• Risperdal (risperidone)

Snippet

Sponsor: Beijing HuiLongGuan Hospital | Conditions: Schizophrenia | NA | Status: UNKNOWN